Literature DB >> 3606083

Rimantadine pharmacokinetics after single and multiple doses.

R J Wills, D A Farolino, N Choma, N Keigher.   

Abstract

Twenty-four healthy adult male volunteers were randomly assigned to one of two rimantadine regimens. The 12 volunteers assigned to regimen 1 orally received a single 100-mg rimantadine tablet followed 5 days later by 100 mg of rimantadine twice a day for 10 days. Volunteers assigned to regimen 2 ingested a single 100-mg rimantadine tablet followed 5 days later by 100 mg once a day for 10 days. The results of the study suggest that the pharmacokinetics of rimantadine are linear and accumulation of the drug during repetitive multiple doses is predictable.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606083      PMCID: PMC174845          DOI: 10.1128/AAC.31.5.826

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

1.  Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics.

Authors:  F G Hayden; H E Hoffman; D A Spyker
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

2.  Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes.

Authors:  P A Patriarca; N A Kater; A P Kendal; D J Bregman; J D Smith; R K Sikes
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

  2 in total
  8 in total

Review 1.  Pharmacokinetics of newer drugs in patients with renal impairment (Part I).

Authors:  J P Fillastre; E Singlas
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

2.  In vitro and in vivo activities of aminoadamantane and aminoalkylcyclohexane derivatives against Trypanosoma brucei.

Authors:  J M Kelly; G Quack; M M Miles
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  The anti-influenza virus drug rimantadine has trypanocidal activity.

Authors:  J M Kelly; M A Miles; A C Skinner
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

4.  Multiple-dose pharmacokinetics of rimantadine in elderly adults.

Authors:  R L Tominack; R J Wills; L E Gustavson; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Effect of cimetidine on the disposition of rimantadine in healthy subjects.

Authors:  A A Holazo; N Choma; S Y Brown; L F Lee; R J Wills
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 6.  Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.

Authors:  D R Guay
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

7.  Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.

Authors:  Marcel Kaiser; Pascal Mäser; Leela Pavan Tadoori; Jean-Robert Ioset; Reto Brun
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

8.  Antiviral agents against respiratory viruses.

Authors:  Cecile L Tremblay
Journal:  Clin Microbiol Newsl       Date:  2001-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.